MEDIA AND BIOTECH STOCKS GET CRUSHED … – Business Insider

First, the scoreboard:Dow: 17,419.75, -120.72, (-0.69%)
S&P 500: 2,083.56, -16.28, (-0.78%)
Nasdaq: 5,056.44, -83.50, (-1.62%)
And now, the top stories on Thursday:Media stocks plunged. Viacom shares dived more than 21% after the company reported lower-than-expected ad revenues from its cable business. The stocks were shaken up by concerns about the cable industry amid the rise of pay TV. Comcast, Time Warner, and 21st Century Fox also declined […]

These are the Biggest Risk to Biotech – Stocks to Watch – Barrons.com

By Ben LevisohnIn a note this morning, BofA Merrill Lynch’s Christina Giannini and team note that the risk for big-cap biotech stocks–think Gilead Sciences (GILD) and Biogen (BIIB)–and small-cap biotech stocks–everything else–are quite different. They explain:
Associated Press

Biotech is now more passive than actively managed: Perhaps due to the difficulty picking stocks within such an idiosyncratic sector given the complicated science […]

It's Bounce Or Else For This Key Stock Market Gauge | Zero Hedge

Via Dana Lyons’ Tumblr,We’ve used much of the space here in the past several weeks pointing out the deteriorating breadth conditions in the U.S. equity market. The trend has been so profound it has now reached the point where it could potentially shift from one of short or intermediate-term relevance to something that might impact the longer-term cyclical bull market. […]

Biotech Bubble; China Crash; Rate Rumble: How Goldman Is Hedging The "What Ifs"

It is no secret that in recent weeks Goldman has been particular bearish (if only to the outside world), with statements such as the following by chief equity strategist David Kostin:

… by almost any measure, US equity valuations look expensive. The typical stock in the S&P 500 trades at 18.1x forward earnings, ranking at the 98th percentile of historical valuation […]

(SPX) – More Evidence China Is In A Stock Market Bubble | Benzinga

Related Berger: Why I Bought Bank Of America Shares This WeekBig Jobs Report Not The Only Headliner—Watch Europe, ChinaBeyond The Biotech Space – Paycom Software Inc NYSE PAYC(Marketfy)A new report by BNP Paribas looks at the extraordinary recent gains in China’s A-share markets and presents the case that China is in the middle of a major equity bubble.BNP lays out […]

Evolent Health begins trading on the NYSE tomorrow (updated …

As we predicted last August, Evolent Health stock will begin trading on the New York Stock Exchange Friday.The shares will debut at $17 under the ticker symbol “EVH”. Evolent will likely have a market cap of more than $800 million.J.P. Morgan Securities LLC and Goldman, Sachs & Co. are acting as joint bookrunners for the offering. Wells Fargo Securities, LLC, William Blair & Company, […]

More Market Nothingness and Biotech Has Me Cautious

This maddening sideways chop continues and the best “risk on” sector, biotech, looks heavy and tired.  The leaders in this space are heavy, AMGN has a bearish head and shoulder pattern going on and CELG and BIIB just cant stop stepping on their feet. GILD acts the best of the big four biotechs.  The other biggie, REGN, continues to hang […]

This biotech stock is a bargain: Strategist – CNBC.com

This biotech stock is a bargain
Options expert Stacey Gilbert explains why Celgene is trading at a discount to its peers.
Investors have been flocking to biotech stocks this year, with the IBB, the ETF that tracks biotech stocks, up nearly 16 percent. But with high returns come high valuations, except in one name, according to a strategist who closely watches the […]

JumpGate – Campaign Guide and Corporate Notes

So I wanted to show off my Savage Worlds campaign guide. This is a set of brief notes, species, equipment, and edges (the notes are currently made for Savage Worlds, but do I plan to make some adjustments for Mini Six and Fudge). All of it detailing a combination of Space Opera, Stars Without Number, and Aliens all sort of […]

STTG Market Recap Mar 25, 2015 – Stock Trading To Go

A very interesting day in the markets as the S&P 500 fell 1.46% and the NASDAQ 2.37%.  Biotechs were crushed today – we’ve been saying the higher they go the more risk they get as they have been on a mostly interrupted run for 4+ years.   That said you just never know when they will correct and even if it’s […]